Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BXQ-350 |
Trade Name | |
Synonyms | SapC-DOPS |
Drug Descriptions |
SapC-DOPS (BXQ-350) is a nanovesicle of saposin C (SapC; a lysosomal protein) and dioleylphosphatidylserine (DOPS) that targets phosphatidylserine to activate lysosomes resulting in apoptosis in cells with high surface levels of phosphatidylserine (Journal of Clinical Oncology 36, no. 15_suppl (May 20 2018) 2517-2517, PMID: 31918715). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C131491 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BXQ-350 | BXQ-350 | 0 | 5 |